SMMNY · Siemens Healthineers AG
Market Cap
$52.47B
Shares
2.24B
Volume · Oct 23
53.54K
Avg daily vol (3M)
66.26K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$23.44
Open$23.30
Day$23.24–23.44
52W close$19.32–28.74
Avg vol 30d77K
Short int137K · 0.0% float · 1.0d
Short vol29%
Last earningsFeb 4, 2027
DataJan 2020–Oct 2026
Up next
Next earnings call
Nov 5, 2026
Scheduled
· in 1 wks
call held Jul 31, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-18.2%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Low
Market backdrop
VIX 19.5 · elevated
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+6%
above
Price vs 50-day avg
+5%
above
RSI (14)
69
neutral
MACD trend
Positive
52-week position
44%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+9%
trailing
6-month return
+16%
trailing
YTD return
−11%
this year
Relative strength
+10%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $22 › 200d $22 — 50d above 200d
Institutional flow
Accumulating
2 of 5 funds reported for Sep 30 · net +3.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +26.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
5 holders — near 3-yr low, contrarian setup
Squeeze score
41
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
26%
annualized · 1-yr
Max drawdown
−33%
past year
ATR
1.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+6%
Bullish
Price vs 50-day avg
+5%
Bullish
RSI (14)
69
Neutral
MACD trend
Positive
Bullish
52-week position
44%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $22 › 200d $22 — 50d above 200d
Institutional flow
Accumulating
2 of 5 funds reported for Sep 30 · net +3.5K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +26.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
5 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $19
Now $23 · 44%
Range high $29
vs 200-day avg +6%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMMNY
this stock
Siemens Healthineers AG
|
$52.47B | -10.6% | — | — | 0.0% |
|
ABT
Abbott Laboratories
|
$180.63B | -17.2% | +5.7% | 33.6 | 0.8% |
|
MDT
Medtronic plc
|
$122.04B | -0.7% | +8.4% | 23.5 | 3.1% |
|
SYK
Stryker Corp
|
$116.86B | -12.6% | +11.2% | 31.6 | 1.5% |
|
BSX
Boston Scientific Corp
|
$66.22B | -52.1% | +12.5% | 18.5 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMMNY | +1.3% | +8.7% | +15.7% | +9.3% | -10.6% |
| SPY | -0.4% | -1.5% | +5.8% | -0.4% | +11.5% |
| vs SPY | +1.8% | +10.2% | +9.9% | +9.7% | -22.1% |
Capital returns
Latest dividend
$0.497
/ share · ex Feb 20, 2025
Paid (TTM)
$0.00
/ share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.